About NeuroRx
NeuroRx is a Healthcare company based in Montreal (Canada) founded in 2003, and was acquired by Clario in March 2025. Clinical trials on neurological diseases are conducted by NeuroRx. NeuroRx offers products and services including Advanced Image Analysis and MRI Trial Management. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service.
Company details
NeuroRx was founded in 2003 and is based in Montreal, Canada. Operations are centered in the clinical research sector, with a focus on trials for neurological diseases. Services include the design, management, and execution of studies to evaluate treatments. The company maintains a presence through its domain, neurorx.com, supporting research initiatives in this specialized field.
- Headquarters Montreal, Canada
- Stage Acquired
- SectorsHealthcare
- Website neurorx.com
- Acquired by Clario (Mar 2025)
Products & Services of NeuroRx
NeuroRx offers a comprehensive portfolio of products and services, including Advanced Image Analysis and MRI Trial Management.
Delivers precise outcome data for clinical trials using advanced techniques.
Manages all activities related to MRI trials in compliant environments.
Investors in NeuroRx
NeuroRx has secured backing from 1 investor. Prominent investors backing the company include Clario.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
CRO focused on providing clinical trial supply services for biopharma sector | 1972 | clario.com | Philadelphia, United States |
Investor details for NeuroRx
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of NeuroRx
2 dated milestones of NeuroRx across 22 years, from founding to its latest funding, stage changes and deals.
- Founded NeuroRx is founded.
- Exit Acquired by Clario.
Web traffic of NeuroRx
The website of NeuroRx (neurorx.com) receives about 4K visits a month.
- Monthly visits4K
▼ 15.4% vs previous month
Websites whose visitors overlap most with NeuroRx. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
tevacanada.com | tevacanada.com | 100% | #1,618,239 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Neurorx
Complete news archive for NeuroRx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NeuroRx
NeuroRx was founded in 2003.
NeuroRx is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.
NeuroRx was founded in 2003 and is based in Montreal, Canada. Operations are centered in the clinical research sector, with a focus on trials for neurological diseases. Services include the design, management, and execution of studies to evaluate treatments. The company maintains a presence through its domain, neurorx.com, supporting research initiatives in this specialized field.
NeuroRx offers Advanced Image Analysis and MRI Trial Management.
NeuroRx has 1 investor. Key investors include Clario.
Yes. NeuroRx was acquired by Clario in March 2025.